Clinical trials: Candidates for Systemic Therapy for Psoriasis, open to volunteers
Psoriasis
LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis
Prospective, Observational Study to Assess the Long-Term Safety of Brodalumab Compared with Other Therapies in the Treatment of Adults with Moderate-to-Severe Psoriasis
- Trial name
- NCT03254667
- Testing
- Brodalumab, Comparator Drug (non-biologic IL-17 inhibitors)
- Where
- United States
- Volunteers
- 3,500 people
- Sponsor
- Bausch Health Americas, Inc.
Ankylosing Spondylitis, Autoimmune Disease
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive immune checkpoint inhibitor drugs.
- Conditions
- Ankylosing Spondylitis, Autoimmune Disease, Crohn Disease, Enteropathic Arthritis
- Trial name
- NCT04751396
- Testing
- Best Practice, Educational Intervention, Interview
- Where
- United States
- Volunteers
- 125 people
- Sponsor
- M.D. Anderson Cancer Center